Comparison of clinical characteristics and prognostic factors in two site-specific categories of ampullary cancer

Table 1 Demographic data and clinical outcomes of ampulla of Vater cancer and duodenal papilla cancer, n (%)

Variables	AVC (n = 145)	DPC (n = 211)	P value
Age, year	59 (52-64)	58 (52-64)	0.78
≤ 60	88 (60.7)	125 (59.2)
> 60	57 (39.3)	86 (40.8)
Sex			0.78
Male	75 (51.7)	106 (50.2)
Female	70 (48.3)	105 (49.8)
BMI, kg/m2			0.50
< 18.5	11 (8.1)	24 (12.1)
18.5-24	96 (71.1)	133 (67.2)
≥ 24	28 (20.8)	41 (20.7)
Diabetes			0.74
Yes	9 (6.2)	15 (7.1)
No	136 (93.8)	196 (92.9)
Neutrophil count, × 109/L	4.17 ± 2.3	4.15 ± 2.3	0.9
Lymphocyte count, × 109/L	1.34 ± 0.4	1.36 ± 0.5	0.88
Blood platelet count, × 109/L	259.89 ± 97.7	251.42 ± 90.8	0.28
Albumin, g/L	35.83 ± 4.80	36.46 ± 4.5	0.35
Tbil, μmol/L	117.19 ± 112.9	88.57 ± 93.8	0.04a
ALT, U/L	138.34 ± 136.5	128.97 ± 109.9	0.77
AST, U/L	112.73 ± 110.1	100.39 ± 84.7	0.93
CA19-9, U/mL	433.35 ± 1405.4	499.65 ± 1807.2	0.61
NLR	3.49 ± 2.42	3.59 ± 3.28	0.86
PLR	215.32 ± 116	205.33 ± 103.43	0.55
PNI	41.99 ± 7.1	42.67 ± 7.34	0.39
ASA			0.10
I	12 (8.3)	26 (12.3)
II	101 (69.7)	155 (73.5)
III	32 (22.1)	30 (14.2)

^aP < 0.05.

BMI: Body mass index; Tbil: Total bilirubin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; NLR: Neutrophil to lymphocyte ratio; PLR: Platelet to lymphocyte ratio; PNI: Prognostic nutritional index; ASA: American Society of Anesthesiologists; AVC: Ampulla of Vater cancer; DPC: Duodenal papilla cancer.